Medtronic and Sanford Health to Develop Stent Graft System for Endovascular Repair
DUBLIN, OH: Medtronic, a medical technology company for endovascular aortic repair is planning to align with South Dakota-based Sanford Health and develop a stent graft system for less invasive treatment of thoracoabdominal aortic aneurysms.
Based on the concept of novel system approved by the U.S. Food and Drug Administration (FDA), patric Kelly, a vascular surgeon from Sandford Health has developed a concept based on the system and by aligning with Medtronic wants to develop devices to treat patients who are not eligible for any other approach for repairing their aneurysm.
The research might help patients live a longer life and therefore developing a standardized stent graft system to address the clinical challenges of repairing thoracoabdominal aortic aneurysms is certainly a great challenge.
“We’re very excited to be working with Dr. Kelly and Sanford Health to develop a standardized stent graft system to address the clinical challenges of repairing thoracoabdominal aortic aneurysms. The exclusive patent license agreement that we’ve entered into with Sanford Health is a further demonstration of how Medtronic collaborates with physicians to foster innovation and develop new therapies that lead to better patient care,” says Daveen Chopra, vice president and general manager of the Aortic franchise, Medtronic.